Azzad Asset Management Inc /Adv Pacira Bio Sciences, Inc. Transaction History

Azzad Asset Management Inc /Adv

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 19, 2024	BUY	$27.7 - $35.48 $5,124 - $6,563	185 Added 2.01%	9,384 $274 Million
Q4 2023 Apr 01, 2024	BUY	$26.32 - $34.31 $242,117 - $315,617	9,199 New	9,199 $310 Million
Q3 2023 Apr 01, 2024	SELL	$30.68 - $40.09 $190,338 - $248,718	-6,204 Closed	0 $0
Q2 2023 Apr 01, 2024	BUY	$36.12 - $47.5 $5,706 - $7,505	158 Added 2.61%	6,204 $249 Million
Q1 2023 Apr 01, 2024	BUY	$35.53 - $43.38 $8,491 - $10,367	239 Added 4.12%	6,046 $247 Million
Q4 2022 Apr 01, 2024	BUY	$38.19 - $57.45 $2,940 - $4,423	77 Added 1.34%	5,807 $224 Million
Q3 2022 Apr 01, 2024	BUY	$51.24 - $58.89 $92,129 - $105,884	1,798 Added 45.73%	5,730 $305 Million
Q2 2022 Apr 01, 2024	BUY	$51.49 - $81.64 $4,222 - $6,694	82 Added 2.13%	3,932 $229 Million
Q1 2022 Apr 01, 2024	SELL	$60.03 - $76.49 $55,047 - $70,141	-917 Reduced 19.24%	3,850 $294 Million
Q4 2021 Apr 01, 2024	SELL	$47.97 - $62.21 $959 - $1,244	-20 Reduced 0.42%	4,767 $287 Million
Q3 2021 Apr 01, 2024	BUY	$54.64 - $61.3 $6,283 - $7,049	115 Added 2.46%	4,787 $268 Million
Q2 2021 Apr 01, 2024	SELL	$59.18 - $69.99 $3,669 - $4,339	-62 Reduced 1.31%	4,672 $284 Million
Q1 2021 Apr 01, 2024	BUY	$59.31 - $78.82 $5,575 - $7,409	94 Added 2.03%	4,734 $332 Million
Q4 2020 Apr 01, 2024	BUY	$50.47 - $66.26 $8,277 - $10,866	164 Added 3.66%	4,640 $278 Million
Q3 2020 Apr 01, 2024	BUY	$51.97 - $63.0 $232,617 - $281,988	4,476 New	4,476 $269 Million

301

51.5M

378K

1.53M

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $673M
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

Get notified when there are updates to the investment portfolio of Azzad Asset Management Inc /Adv, based on Form 13F filings with the SEC.

Stay updated on Azzad Asset Management Inc /Adv with notifications on news.